Sars Cov 2
India  /  Published 10.06.22

Central alert as Covid cases rise

The Union health ministry on Thursday alerted all states to a 58 per cent rise in the national average daily new Covid-19 cases over the past week amid uncertainty over what is driving the upsurge and...
By G.S. Mudur in New Delhi

Health  /  Published 19.05.22

Why didn't I get Covid? Is it just luck?

We all know a few of those lucky people who, somehow, have managed to avoid ever catching COVID. Perhaps you're one of them. Is this a Marvel-esque superpower? Is there any scientific reason why a...
By Lindsay Broadbent in London

India  /  Published 11.05.22

Funds for jab to beat variants

A global vaccine development coalition has decided to fund an India-Australia-Switzerland  research consortium to create a novel so-called “variant-proof” coronavirus vaccine for broa...
By G.S. Mudur in New Delhi

India  /  Published 01.05.22

Cholesterol drug to fight Covid?

Scientists in Calcutta and Kalyani have generated fresh evidence for the idea circulating in medical circles for months that fluvastatin, a drug used to lower cholesterol, might also work against SARS...
By GS Mudur in New Delhi

India  /  Published 29.04.22

Veil on Covid variant data disappoints scientists

A central government research consortium tasked with sequencing coronavirus variants nationwide has consistently delayed data release for scientific scrutiny and provided patchy data to its own scient...
By G.S. Mudur in New Delhi


News  /  Published 20.04.22

Another Covid wave unlikely, new variants may cause sporadic hike in cases

Even as genome scientists analyse the role of recombinant coronavirus variants in the recent increase in Covid cases in parts of India, senior public health experts and doctors have opined that the in...
By The Plurals News Network in Kolkata

India  /  Published 10.03.22

Virus’s 7-month mutation voyage

Scientists have for the first time traced the step-by-step chronological evolution of an inconspicuous SARS-CoV-2 strain into a variant with 50 per cent mutations shared by omicron over seven months i...
By G.S. Mudur in New Delhi

India  /  Published 09.03.22

Staying masked up post vax saves lives: Study

The researchers who have estimated the potential benefits of face masks in the US population at 70 to 90 per cent vaccination coverage said their results may apply to other countries, providing estima...
By Our Special Correspondent in New Delhi

India  /  Published 22.02.22

Funds push for India's efforts to develop a broad-acting vaccine

A global vaccine development coalition has agreed to fund an Indian academic-industry research effort to develop a broad-acting vaccine against SARS-CoV-2, the virus that causes Covid-19, and other cl...
By G.S. Mudur in New Delhi

India  /  Published 19.02.22

IISc scientists find hope of anti-viral Covid shield

Indian scientists have identified a naturally-occurring biochemical in the human body as a potential broad-acting antiviral agent that could serve as a shield against multiple viruses, including influ...
By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.